FDA Drafts Rules for Updating Drug Safety Labels
Published Date: 9/19/2025
Notice
Summary
The FDA just released a draft guide to help drug makers update safety labels when new risks pop up after a drug is approved. This affects companies that hold drug or biological product applications, making sure labels stay accurate and safe. The updated guide reflects recent law changes and current FDA rules, so watch for final rules soon—this could impact how quickly companies must act and possibly their costs.
Analyzed Economic Effects
2 provisions identified: 0 benefits, 2 costs, 0 mixed.
FDA may require post‑approval label changes
The draft guidance explains that under Section 505(o)(4) the FDA can require holders of certain drug and biological product applications to make labeling changes when new safety information appears after approval and FDA determines it should be added to the label. This requirement applies to application holders for those products.
Guidance updates include 2018 reduced‑effectiveness rule
The draft revises and, when finalized, will replace the July 2013 guidance. It adds information reflecting Congress' 2018 changes to the definition of adverse drug experience about reduced effectiveness and updates FDA processes and procedures for safety labeling changes.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11762 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Procedures for the Safe Processing and Importing of Fish and Fishery Products
The FDA is asking for approval to keep collecting info from seafood processors and importers to make sure fish products are safe using a system called HACCP. This affects anyone who processes or imports fish and requires them to keep records showing they’re following safety rules. Comments on this plan are open until July 13, 2026, and there’s no new cost, just a continuation of current paperwork.
2026-11740 — Medical Devices; Immunology and Microbiology Devices; Classification of the Spinal Muscular Atrophy Newborn Screening Test System
The FDA is officially putting the Spinal Muscular Atrophy (SMA) newborn screening test into class II, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps make the test safer and easier to get to babies who need it, starting June 11, 2026, with the classification effective since November 2022. Labs and device makers will benefit from clearer rules and faster access, helping catch SMA early without extra costs or delays.
2026-11739 — Medical Devices; Immunology and Microbiology Devices; Classification of the Simple Point-of-Care Device to Directly Detect SARS-CoV-2 Viral Targets From Clinical Specimens in Near-Patient Settings
The FDA is officially putting simple COVID-19 rapid test devices into a safer, easier-to-manage category called Class II. This change means these tests can get to patients faster and with fewer hoops to jump through, while still making sure they work well and stay safe. Starting June 11, 2026, companies making these tests will follow new rules that help speed up innovation without extra costs.
2026-11760 — Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Establishment, Maintenance, and Availability of Records; Additional Traceability Records for Certain Foods
The FDA is asking for approval to collect extra records from food businesses that handle certain high-risk foods. This helps track food sources quickly to keep everyone safe. Food companies should get ready to keep and share these new records, and comments on this plan are due by July 13, 2026.
2026-11578 — Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use, and Related Information
The FDA just gave a thumbs-up to adding bemotrizinol as a new active ingredient in sunscreens, letting it be used up to 6% concentration. This means sunscreen makers can now include this ingredient, which is safe and effective, in their products. The change is official as of June 10, 2026, and could lead to better sun protection options without extra costs for consumers.
2026-11589 — Medical Devices; Ear, Nose, and Throat Devices; Classification of the Combined Acoustic and Electrical External Stimulation Device for the Relief of Tinnitus
The FDA has officially placed the combined acoustic and electrical external stimulation device for tinnitus relief into class II, meaning it now has special safety rules but fewer regulatory hurdles. This change helps patients get access to this innovative device faster and ensures it’s safe and effective. The new classification is effective June 10, 2026, with the rules applying retroactively from March 6, 2023.
Previous / Next Documents
Previous: 2025-18148 — Self-Regulatory Organizations; Municipal Securities Rulemaking Board; Order Approving a Proposed Rule Change To Amend Rule G-14 RTRS Procedures Under MSRB Rule G-14 Regarding the Timing of Reporting Transactions in Municipal Securities to the MSRB and To Make a Related Amendment to Rule G-12
The Municipal Securities Rulemaking Board (MSRB) is keeping the current 15-minute rule for brokers and dealers to report municipal bond trades, instead of shortening it. They’re also removing some exceptions and updating related rules to keep things clear and consistent. This means no rushed reporting changes for now, helping everyone stay on the same page without extra costs or confusion.
Next: 2025-18154 — Foreign Endangered Species; Receipt of Permit Applications
The U.S. Fish and Wildlife Service is asking the public to share their thoughts on requests to work with endangered animals from other countries. These activities usually need special permission to make sure the animals stay safe. If you care about protecting these rare species, now’s the time to speak up before permits are approved!